The effect of PON1 enhancers on reducing acetylcholinesterase inhibition following organophosphate anticholinesterase exposure in rats.

作者: Edward C. Meek , Howard W. Chambers , Ronald B. Pringle , Janice E. Chambers

DOI: 10.1016/J.TOX.2015.08.002

关键词:

摘要: Novel nucleophiles, a series of substituted phenoxyalkyl pyridinium oximes, have been previously shown by our laboratories to enhance in vitro paraoxonase 1 (PON1)-mediated degradation sarin surrogate (nitrophenyl isopropyl methylphosphonate, NIMP) and VX ethyl NEMP). Five the most efficacious these nucleophiles were tested rats for their ability reduce level acetylcholinesterase (AChE) inhibition brain peripheral tissues following exposure NIMP or NEMP. Following simultaneous administration nucleophile plus (at 3 dosages yielding about 10-50% AChE at 15 min), all five reduced dosages, lowest dosage. Protective effects seen only short period time, i.e., min. Even though are they not effective reactivators so it is unlikely that resultant decreases from appreciable reactivation. It likely protective are, least part, result enhancement PON1-mediated degradation, an unprecedented mechanism therapy has potential be developed into nerve agent countermeasure.

参考文章(15)
A. Lewis Farr, Oliver H. Lowry, Rose J. Randall, Nira J. Rosebrough, Protein Measurement with the Folin Phenol Reagent Journal of Biological Chemistry. ,vol. 193, pp. 265- 275 ,(1951)
George L. Ellman, K.Diane Courtney, Valentino Andres, Robert M. Featherstone, A new and rapid colorimetric determination of acetylcholinesterase activity Biochemical Pharmacology. ,vol. 7, pp. 88- 95 ,(1961) , 10.1016/0006-2952(61)90145-9
Nicola Martinelli, Domenico Girelli, Oliviero Olivieri, Patrizia Guarini, Antonella Bassi, Elisabetta Trabetti, Simonetta Friso, Francesca Pizzolo, Claudia Bozzini, Ilaria Tenuti, Laura Annarumma, Renzo Schiavon, Pier Franco Pignatti, Roberto Corrocher, Novel serum paraoxonase activity assays are associated with coronary artery disease. Clinical Chemistry and Laboratory Medicine. ,vol. 47, pp. 432- 440 ,(2009) , 10.1515/CCLM.2009.108
Rebecca J. Richter, Clement E. Furlong, Determination of paraoxonase (PON1) status requires more than genotyping. Pharmacogenetics. ,vol. 9, pp. 745- 753 ,(1999) , 10.1097/00008571-199912000-00009
Kimberly A. Davis, J. Allen Crow, Howard W. Chambers, Edward C. Meek, Janice E. Chambers, Racial differences in paraoxonase-1 (PON1): a factor in the health of southerners? Environmental Health Perspectives. ,vol. 117, pp. 1226- 1231 ,(2009) , 10.1289/EHP.0900569
Steven Z. Fairchild, Matthew W. Peterson, Adel Hamza, Chang-Guo Zhan, Douglas M. Cerasoli, Wenling E. Chang, Computational characterization of how the VX nerve agent binds human serum paraoxonase 1 Journal of Molecular Modeling. ,vol. 17, pp. 97- 109 ,(2011) , 10.1007/S00894-010-0693-9
Stephen D. Kirby, Joseph R. Norris, J. Richard Smith, Brian J. Bahnson, Douglas M. Cerasoli, Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents Chemico-Biological Interactions. ,vol. 203, pp. 181- 185 ,(2013) , 10.1016/J.CBI.2012.10.023
Janice E. Chambers, Howard W. Chambers, Edward C. Meek, Kristen E. Funck, Manikanthan H. Bhavaraju, Steven R. Gwaltney, Ronald B. Pringle, Novel Nucleophiles Enhance the Human Serum Paraoxonase 1 (PON1)-mediated Detoxication of Organophosphates Toxicological Sciences. ,vol. 143, pp. 46- 53 ,(2015) , 10.1093/TOXSCI/KFU205
Janice E. Chambers, Howard W. Chambers, Edward C. Meek, Ronald B. Pringle, Testing of novel brain-penetrating oxime reactivators of acetylcholinesterase inhibited by nerve agent surrogates Chemico-Biological Interactions. ,vol. 203, pp. 135- 138 ,(2013) , 10.1016/J.CBI.2012.10.017
Rahul Sharma, Bhanushree Gupta, Namrata Singh, JR Acharya, Kamil Musilek, Kamil Kuca, Kallol Kumar Ghosh, Development and Structural Modifications of Cholinesterase Reactivators against Chemical Warfare Agents in Last Decade: A Review. Mini-reviews in Medicinal Chemistry. ,vol. 15, pp. 58- 72 ,(2015) , 10.2174/1389557514666141128102837